Interesting, product thinking analysis of drug series

Hello, everyone Today's editor in chief, the old beggar of Tianqiao, I will bring you a drug report about ocaliva, which is different from the traditional report mode The old beggar will use the Internet product thinking to try to briefly analyze the relevant situation of a drug For the first time, if there is any deficiency, please give me some advice from the professionals and industry leaders Let's start with the old beggar If you want to be good at your work, you must first sharpen your tools Yes, we need to prepare tools for the homepage We can start with the following tools: 1 Google search (please master the correct way of use); 2 Intelligence data; 3 BDP (visual analysis tool); 4 Photoshop, 5 Baidu brain map (mind mapping tool) Backup lineup: Baidu search, Excel, tableau, maker post, XMIND Then we started: the first way: open the brain hole, determine the module (use mind mapping tools to draw the general framework of drugs), such as: basic information, research and development, competitive products, market and other modules to expand and analyze Roughly draw the following thought map, which can be continuously deepened and expanded according to your own needs The second way: search all over the world, sort out the data (skillfully use various search tools) according to the previous mind map module by module to collect the corresponding data and information for processing For example, if you want to know the basic information of the drug first, you can use Google to search, refer to the FDA website, drug.com, drug intelligence data - global drug R & D database and other information sources, and sort out the following basic information Then sort out some specific treatment areas and user needs of the drug: user group: the number of patients with nonalcoholic steatohepatitis is huge, and the number of patients worldwide accounts for about 2% - 3% of the total global population At present, there is no drug approved to treat nonalcoholic steatohepatitis, and the market space is huge User requirements: primary biliary cholangitis is a chronic type of liver disease that can gradually destroy the bile duct These pipes carry bile from the liver to the small intestine to help the body digest fat and certain vitamins When bile ducts are destroyed by PBC, bile stays in the liver and damages hepatocytes, which can lead to cirrhosis (scarring of the liver) and liver failure PBC is a slowly progressive disease that may not have symptoms for many years Treatment of PBC to maintain normal liver function can lead to normal life expectancy Before ocaliva was approved, UDCA was the only drug approved for PBC treatment, but many PBC patients could not tolerate UDCA or had poor efficacy when receiving UDCA treatment, so ocaliva's approval met the major needs of these patients that had not been met before, "said Dr John vierling, Professor of internal medicine and surgery at Baylor Medical College and former chairman of American Society of Hepatology "Ocaliva's improvements in reducing ALP are clinically significant (ALP is a biomarker used to track disease progression in PBC patients) It is important that ocaliva achieves a sustained ALP reduction, which is essential for the treatment of chronic diseases such as PBC " This basically completes a brief introduction of the basic information of the drug Then it collects and sorts out the information around the R & D module First, we use drug.com to query ocaliva's R & D history information Get information like this Combined with EMA, we can find out the relevant listing information of EU After finishing the processing, we can make the following more intuitive results Then, we began to collect the patent information of ocaliva Using Google patents tool, combined with the patent of Yaozhi (the annual popular product), query, sort out and analyze the following data table After sorting out the relevant data, we can get: obetichoicacid related patents: 186, belonging to the same family: 96; the number of patents belonging to intercept pharmaceuticals: 36, belonging to the same family: 9 Based on the analysis of 9 patents under intercept pharmaceuticals, 36 patent distribution countries and regions are as follows: the United States (9), WIPO (7), Australia (5), Singapore (2), Canada (1), Chile (1), China (1) Colombia (1), EPO (1), Hong Kong (1), Israel (1), India (1), Japan (1), New Zealand (1), the Philippines (1), Taiwan (1) and the above sorted data lay a good foundation for later visual analysis Then, we query and collate the relevant clinical trial data of octalva through the intelligence of medicine data global clinical trial database Get the following data table: then, we continue to use Google to query the official website of intercept pharmaceuticals, the drug R & D enterprise, and download the annual report of the company We can also obtain the annual report through the SEC, from which we can sort out and analyze competitive product information and market sales data Combined with the specific clinical trial data, the competitive products sorted out the following data tables: market data obtained: since the second quarter of 2016, the sales were 7.5W, 470w, 1340w respectively, with a total annual amount of 1820w US dollars 13.62% of the company's product revenue It can also obtain some R & D expense information The last move: integrate and optimize, play the last set of combo boxing, and it will be a perfect ending The last step is to use BDP, Excel, tableau, Photoshop and other tools to integrate the data information sorted out before Output a relatively complete drug report Generally speaking, there are three core steps to analyze drugs with product thinking: 1 Mind mapping, planning module and architecture 2 According to the architecture, the modules use search tools to collect the corresponding data 3 Integrate modular information into a complete product It's that simple According to the method of Xiaobian, we can use this angle to output various drug reports Xiaobian's first sharing is almost here, but it's not over First, let's take a screenshot The figure below is the ocaliva report created by using product thinking If you are interested, please leave a message for HD report Finally, thank you for your reading and the first attempt of Xiaobian There are still many shortcomings Please forgive me If you need, please add QQ: 2833586267 to communicate with each other Attachment: product thinking and drugs - ocaliva report PDF original statement: This article is the original manuscript of yaozhi.com, welcome to reprint, reprint please indicate the source and author, thank you!